YKL‐40 as a Biomarker of Inflammation in Chronic Insomnia: A Potential Pathway to Alzheimer's Disease
Our findings suggest that insomnia severity in individuals diagnosed with insomnia is linked to elevated YKL-40 concentrations, independently of multiple confounders. However, the comorbidity between insomnia and mental disorders may play a key role in the selective vulnerability to AD. Future studies should evaluate the interaction of insomnia severity and mental health symptomatology when predicting AD risk and related processes.
Authors
- Caroline d'Aragon
- REBECCA ROBILLARD
- Alex Désautels (ORCID: https://orcid.org/0000-0002-2495-5675)
- Beatriz Helena Domingos Oliveira
- Nadia Gosselin (ORCID: https://orcid.org/0000-0002-3370-1634)
- Mélanie Vendette
- Erlan Sanchez
- Julie Otis
- Julie Carrier
- Nicole Lazarovici
- Marie‐Josée Quinn
- Andrée‐Ann Baril
- Rayan Daoudi
Institutions
- University of Ottawa (CA)
- Hôpital du Sacré-Cœur de Montréal (CA)
- McGill University (CA)
- Université de Montréal (CA)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70858_098789
- Primary Topic
- Sleep and related disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00